Pathology and Pathogenesis of SARS-CoV-2 Associated with Fatal Coronavirus Disease, United States

An ongoing pandemic of coronavirus disease (COVID-19) is caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Characterization of the histopathology and cellular localization of SARS-CoV-2 in the tissues of patients with fatal COVID-19 is critical to further underst...

Full description

Saved in:
Bibliographic Details
Published in:Emerging infectious diseases Vol. 26; no. 9; pp. 2005 - 2015
Main Authors: Martines, Roosecelis B, Ritter, Jana M, Matkovic, Eduard, Gary, Joy, Bollweg, Brigid C, Bullock, Hannah, Goldsmith, Cynthia S, Silva-Flannery, Luciana, Seixas, Josilene N, Reagan-Steiner, Sarah, Uyeki, Timothy, Denison, Amy, Bhatnagar, Julu, Shieh, Wun-Ju, Zaki, Sherif R
Format: Journal Article
Language:English
Published: United States U.S. National Center for Infectious Diseases 01-09-2020
Centers for Disease Control and Prevention
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:An ongoing pandemic of coronavirus disease (COVID-19) is caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Characterization of the histopathology and cellular localization of SARS-CoV-2 in the tissues of patients with fatal COVID-19 is critical to further understand its pathogenesis and transmission and for public health prevention measures. We report clinicopathologic, immunohistochemical, and electron microscopic findings in tissues from 8 fatal laboratory-confirmed cases of SARS-CoV-2 infection in the United States. All cases except 1 were in residents of long-term care facilities. In these patients, SARS-CoV-2 infected epithelium of the upper and lower airways with diffuse alveolar damage as the predominant pulmonary pathology. SARS-CoV-2 was detectable by immunohistochemistry and electron microscopy in conducting airways, pneumocytes, alveolar macrophages, and a hilar lymph node but was not identified in other extrapulmonary tissues. Respiratory viral co-infections were identified in 3 cases; 3 cases had evidence of bacterial co-infection.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1080-6040
1080-6059
DOI:10.3201/eid2609.202095